Neuromuscular Blockade MonitoringNCT07394140
NMT EasyFit Sensor and Cable
A study testing Collection of NMT Technology in people with Neuromuscular Blockade Monitoring and NMT, run by GE Healthcare at 1 site in United States.
Trial summary
The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Neuromuscular Blockade Monitoring, NMT
- What is being tested?
- Collection of NMT Technology
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 18 Jun 2026to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Study subject (male or female) is age 18 years or older (≥18 years).
- Study subject must have the ability to understand and provide written informed consent.
- Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication.
- Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm.
Who cannot join
- Are known to be pregnant.
- Are breastfeeding.
- Suffering from an infection(s) that requires isolation.
- Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject.
- Subjects requiring rapid sequence induction
- Subjects expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be used in the study.
- Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules).
- NMT ElectroSensor placed on the foot/ankle
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Loma Linda University Health
Loma Linda, California, 92354
Melissa McCabe, 909-558-4256, mmcabe@llu.edu
Melissa McCabe, MD
About this study
Official title: Evaluate Functionality and Use of the NMT EasyFit Sensor and NMT EasyFit Cable
The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable.
Read the detailed description
The NMT Sensor provides quantitative, automated measurements of neuromuscular block by delivering non-invasive electrical stimuli to the ulnar nerve and recording electromyography (EMG) responses from the adductor pollicis muscle. Surface hydrogel electrodes with adhesive foam ensure secure placement for continuous monitoring. The single-use sensor connects to a reusable NMT Cable and is designed for use with GE HealthCare NMT measurement devices (NMT Module and bedside monitors).
- Conditions
- Neuromuscular Blockade Monitoring, NMT
- Being tested
- Collection of NMT Technology
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Collection of NMT TechnologyDevice
Collection and assessment of non-invasive electrical stimuli from the NMT measurement placed on the patient's hand and forearm to measure the level of neuromuscular blocking agents during standard of care surgical procedures.
| Study group | Role | What they receive |
|---|---|---|
| All Subjects | Experimental | Placement of NMT Sensor on Hand and Forearm Receives: Device: Collection of NMT Technology |
What is being measured
The primary outcome is the main question the study is designed to answer.
Collection of End User Feedback Surveys
Collection of end user feedback surveys on the functionality and clinical use of the NMT Sensor and Cable during standard of care surgical procedure (minimum of 1 hour and maximum of 24 hours).
Measured: Up to 24 hours
Secondary outcomes (2)
Collection of raw parameter data from NMT Sensor and Cable
Collection of raw parameter data from NMT Sensor and Cable to evaluate the reliability of the measurements to NMBA concordance rate.
Measured: Up to 24 hours
Incidence of Safety Events
Analysis of adverse events will be listed per subject, summarized with counts and percentages of events, and summarized with counts and percentages of subjects with events.
Measured: 4 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Feb 2026
- Study start18 Jun 2026
- Primary completion31 Oct 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Neuromuscular Blockade MonitoringStudies of the same condition, open and under way.
- More trials run by GE HealthcareThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- GE Healthcare
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Loma Linda University
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07394140
- Sponsor's protocol ID
- SA-000175
- Status last verified
- Jul 2026
- First submitted
- 2 Feb 2026
- Last updated
- 8 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 8 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluate Functionality and Use of the NMT EasyFit Sensor and NMT EasyFit Cable
- ClinicalTrials.gov ID
- NCT07394140
- Acronym / sponsor ID
- SA-000175
- Conditions
- Neuromuscular Blockade Monitoring, NMT
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- GE HealthcareIndustry (pharma, biotech, devices)
- Collaborators
- Loma Linda University
- Study start
- 18 Jun 2026 (actual)
- Primary completion
- 31 Oct 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 6 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable.
Detailed description
The NMT Sensor provides quantitative, automated measurements of neuromuscular block by delivering non-invasive electrical stimuli to the ulnar nerve and recording electromyography (EMG) responses from the adductor pollicis muscle. Surface hydrogel electrodes with adhesive foam ensure secure placement for continuous monitoring. The single-use sensor connects to a reusable NMT Cable and is designed for use with GE HealthCare NMT measurement devices (NMT Module and bedside monitors).
Study design
- Primary purpose
- Device feasibility
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| All Subjects | Experimental | Device: Collection of NMT TechnologyPlacement of NMT Sensor on Hand and Forearm |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Study subject (male or female) is age 18 years or older (≥18 years).
- Study subject must have the ability to understand and provide written informed consent.
- Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication.
- Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm.
Key exclusion criteria (8 listed)
- Are known to be pregnant.
- Are breastfeeding.
- Suffering from an infection(s) that requires isolation.
- Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject.
- Subjects requiring rapid sequence induction
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Collection of NMT TechnologyCollection and assessment of non-invasive electrical stimuli from the NMT measurement placed on the patient's hand and forearm to measure the level of neuromuscular blocking agents during standard of care surgical procedures. | Device | All Subjects |
Primary outcome
Collection of End User Feedback Surveys
Time frame: Up to 24 hours
Collection of end user feedback surveys on the functionality and clinical use of the NMT Sensor and Cable during standard of care surgical procedure (minimum of 1 hour and maximum of 24 hours).
2 secondary outcomes
Collection of raw parameter data from NMT Sensor and Cable
Time frame: Up to 24 hours
Incidence of Safety Events
Time frame: 4 months.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jul 2026.
Related trials for Neuromuscular Blockade Monitoring
Recruiting
Low-Dose Rocuronium Maintenance During Spine Surgery With Intraoperative Neurophysiological Monitoring
Spine Surgery, Intraoperative Neurophysiological Monitoring
Recruiting
TwichView-guided Atricurium Dose Adjustment Trial
ARDS, TTM
Recruiting
Monitoring of Neuromuscular Blockade in the Intensive Care Unit: a Reliability Study
Neuromuscular Blockade Monitoring
Recruiting
Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal
Neuromuscular Blockade Reversal Agent, Perioperative Complications
Active, not recruitingObservational study
Predicting Neuromuscular Recovery in Surgical Patients Using Machine Learning
Residual Paralysis, Post Anesthesia, Postoperative Complications
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Collection of NMT Technology in people with Neuromuscular Blockade Monitoring and NMT, run by GE Healthcare at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Melissa McCabe, MD (909-558-4475, mmccabe@llu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Collection of End User Feedback Surveys (time frame: Up to 24 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026; AzTrials last refreshed its copy on 26 Oct 2026.